Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
73
EXLS Quote, Financials, Valuation and Earnings
Last price:
$45.99
Seasonality move
:
3.9%
Day range:
$45.80 - $46.35
52-week range:
$28.59 - $52.43
Dividend yield:
0%
P/E ratio:
34.84x
P/S ratio:
3.96x
P/B ratio:
7.39x
Volume:
1.6M
Avg. volume:
1.5M
1-year change:
55.48%
Market cap:
$7.5B
Revenue:
$1.8B
EPS (TTM):
$1.32
Analysts' Opinion
-
Consensus RatingExlService Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $54.35, ExlService Holdings has an estimated upside of 18.17% from its current price of $45.99.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $52.00 representing 100% downside risk from its current price of $45.99.
Fair Value
-
According to the consensus of 7 analysts, ExlService Holdings has 18.17% upside to fair value with a price target of $54.35 per share.
EXLS vs. S&P 500
-
Over the past 5 trading days, ExlService Holdings has underperformed the S&P 500 by -1.56% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
ExlService Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ExlService Holdings has grown year-over-year revenues for 17 quarters straight. In the most recent quarter ExlService Holdings reported revenues of $501M.
Earnings Growth
-
ExlService Holdings has grown year-over-year earnings for 3 quarters straight. In the most recent quarter ExlService Holdings reported earnings per share of $0.40.
Enterprise value:
7.5B
EV / Invested capital:
--
Price / LTM sales:
3.96x
EV / EBIT:
24.94x
EV / Revenue:
3.92x
PEG ratio (5yr expected):
1.57x
EV / Free cash flow:
30.35x
Price / Operating cash flow:
30.66x
Enterprise value / EBITDA:
19.46x
Gross Profit (TTM):
$721.2M
Return On Assets:
13.77%
Net Income Margin (TTM):
11.36%
Return On Equity:
23.98%
Return On Invested Capital:
17.64%
Operating Margin:
15.65%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $1.7B | $1.9B | $436.5M | $501M | |
| Gross Profit | $542.9M | $621.7M | $721.2M | $163.1M | $193.3M | |
| Operating Income | $207.6M | $240.8M | $280.5M | $61.5M | $78.4M | |
| EBITDA | $289.4M | $328.7M | $383.3M | $83.2M | $103.9M | |
| Diluted EPS | $0.93 | $1.08 | $1.32 | $0.29 | $0.40 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $596.6M | $572.6M | $566.2M | $664.7M | $831.3M | |
| Total Assets | $1.2B | $1.3B | $1.3B | $1.4B | $1.7B | |
| Current Liabilities | $197.7M | $222.1M | $280.9M | $261.4M | $243.7M | |
| Total Liabilities | $500.1M | $574.2M | $513.3M | $636.1M | $664.5M | |
| Total Equity | $726.2M | $700.3M | $795.2M | $803.3M | $1B | |
| Total Debt | $227.7M | $295M | $200M | $345M | $307.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $209M | $173.3M | $293.6M | -$21.9M | $3.2M | |
| Cash From Investing | -$48.5M | -$50.6M | -$146.1M | $4.7M | -$22.3M | |
| Cash From Financing | -$176.6M | -$99.9M | -$105.9M | -$9.8M | $3.4M | |
| Free Cash Flow | $167.8M | $121.7M | $245.7M | -$33.1M | -$9.7M | |
EXLS
Sector
Market Cap
$7.5B
$602.8M
Price % of 52-Week High
87.72%
77.23%
Dividend Yield
0%
0%
Shareholder Yield
0.6%
2.32%
1-Year Price Total Return
55.48%
-3.86%
Beta (5-Year)
0.855
0.777
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$46.05
200-day SMA
Buy
Level
$43.99
Bollinger Bands (100)
Sell
Level
44.82 - 49.38
Chaikin Money Flow
Buy
Level
254.9M
20-day SMA
Sell
Level
$46.17
Relative Strength Index (RSI14)
Buy
Level
50.05
ADX Line
Buy
Level
9.53
Williams %R
Neutral
Level
-68.6709
50-day SMA
Buy
Level
$45.74
MACD (12, 26)
Buy
Level
0.08
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
197.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.4489)
Buy
CA Score
(Annual)
Level (1.2673)
Buy
Beneish M-Score
(Annual)
Level (-2.7499)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.6434)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.
Stock Forecast FAQ
In the current month, EXLS has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The EXLS average analyst price target in the past 3 months is $54.35.
-
Where Will ExlService Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that ExlService Holdings share price will rise to $54.35 per share over the next 12 months.
-
What Do Analysts Say About ExlService Holdings?
Analysts are divided on their view about ExlService Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ExlService Holdings is a Sell and believe this share price will drop from its current level to $52.00.
-
What Is ExlService Holdings's Price Target?
The price target for ExlService Holdings over the next 1-year time period is forecast to be $54.35 according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is EXLS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ExlService Holdings is a Buy. 5 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EXLS?
You can purchase shares of ExlService Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ExlService Holdings shares.
-
What Is The ExlService Holdings Share Price Today?
ExlService Holdings was last trading at $45.99 per share. This represents the most recent stock quote for ExlService Holdings. Yesterday, ExlService Holdings closed at $45.99 per share.
-
How To Buy ExlService Holdings Stock Online?
In order to purchase ExlService Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
